Honasa buys 58% of Fluence Pharma for Rs 135 Cr, launches Honasa Health for nutraceuticals push
Mamaearth parent acquires majority stake in dermatologist-led nutraceuticals firm Fluence Pharma at Rs 135 crore EV, with remaining 42% to be picked up over 5-7 years. New subsidiary Honasa Health will tap the Rs 16,000 crore inside-out beauty market via D2C, leveraging a 3,000-dermatologist network.
Honasa Consumer acquires 58% of nutraceuticals firm Fluence Pharma at Rs 135 crore EV, with remaining 42% over 5-7 years. Forms Honasa Health subsidiary to enter D2C nutraceuticals, leveraging Fluence's dermatologist network and CNT platform for inside-out beauty.